Table 1.
Selected clinical trials of venetoclax in chronic lymphocytic leukemia (CLL).
| ClinicalTrials.Gov Identifier | Other Study ID Numbers | Intervention | Disease | Study Phase(s) | Publications |
|---|---|---|---|---|---|
| VEN monotherapy | |||||
| NCT01328626 | M12-175 | VEN | R/R CLL | 1 | [46] |
| NCT01889186 | M13-982 | VEN | R/R CLL with del(17p) | 2 | [49,71] |
| NCT02141282 | M14-032 | VEN | R/R CLL after BCR inhibitor therapy | 2 | [50,51] |
| VEN combination therapy | |||||
| NCT01682616 | M13-365 | VEN + R | R/R CLL/SLL | 1b | [53] |
| NCT02005471 | GO28667, MURANO | VEN + R | R/R CLL | 3 | [54,72] |
| NCT02242942 | BO25323, CLL14 | VEN + G | CLL | 3 | [57] |
| NCT02756897 | 2015-0860 | VEN + IBR | R/R CLL | 2 | [65] |
| NCT02427451 | OSU-14266, NCI-2015-00252 | VEN + IBR + G | R/R CLL | 1b/2 | [67] |
| NCT02401503 | CLL2-BAG, 2014-000580-40 | Bendamustine + VEN + G | CLL | 2 | [70] |